NASDAQ: XERS · Health Care / Biotechnology: Pharmaceutical Preparations

Xeris Biopharma Holdings Inc.

How Xeris Biopharma Holdings Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.0B

Price

$10.75

P/E

-108.7

EPS (TTM)

$-0.10

1-year return

11.7%

Dividend yield

0.0%

52-week range

$6.84–$11.13

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources